Omnicell Investor Presentation Deck slide image

Omnicell Investor Presentation Deck

Convertible senior notes, net Cash and cash equivalents Net debt Net debt Non-GAAP EBITDA Long-term debt, current portion, net Long-term debt, net Total debt, net Cash and cash equivalents Net debt Net debt/Non-GAAP EBITDA (a) © 2023 Omnicell, Inc. Quarter Ended March 31, 2023 S S $ Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) S Year Ended December 31, 2017 S 567,342 (340,413) 226,929 1.3 15,208 194,917 210,125 (32,424) 177,701 1.9 *Net Debt / EBITDA= (Total Debt-Cash and Cash Equivalents)/Trailing Twelve Months Non-GAAP EBITDA Revolver availability Cash and cash equivalents Liquidity Revolver availability Cash and cash equivalents Liquidity Quarter Ended March 31, 2023 S S Year Ended December 31, 2017 S 500,000 340,413 840,413 S 280,500 32,424 312,924 26
View entire presentation